Organovo Holdings Inc (ONVO)
0.40
+0.05
(+14.32%)
USD |
NASDAQ |
Nov 22, 16:00
0.395
0.00 (0.00%)
After-Hours: 20:00
Organovo Holdings Gross Profit Margin (Quarterly): 96.67% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 96.67% |
June 30, 2024 | 94.87% |
March 31, 2024 | |
December 31, 2023 | |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 |
Date | Value |
---|---|
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 95.64% |
September 30, 2019 | 78.54% |
June 30, 2019 | 92.37% |
March 31, 2019 | 85.15% |
December 31, 2018 | 82.54% |
September 30, 2018 | 86.74% |
June 30, 2018 | 82.58% |
March 31, 2018 | 74.39% |
December 31, 2017 | 83.35% |
September 30, 2017 | 81.25% |
June 30, 2017 | 69.60% |
March 31, 2017 | 77.46% |
December 31, 2016 | 81.58% |
September 30, 2016 | 71.44% |
June 30, 2016 | 81.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
94.87%
Minimum
Jun 2024
96.67%
Maximum
Sep 2024
95.73%
Average
95.64%
Median
Dec 2019
Gross Profit Margin (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 77.14% |
IGC Pharma Inc | 48.06% |
NovaBay Pharmaceuticals Inc | 65.26% |
Protalix BioTherapeutics Inc | 53.37% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -219.4% |
Return on Assets | -147.2% |
Return on Invested Capital | -219.4% |
Profit Margin (Quarterly) | -8.50K% |
Operating Margin (Quarterly) | -8.69K% |
Return on Net Operating Assets | -518.6% |